Empagliflozin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Safety and Efficacy of Empagliflozin in Hemodialysis
Condition:   End Stage Renal Disease Interventions:   Drug: Empagliflozin 10 MG;   Drug: Placebo Sponsors:   NYU Langone Health;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2023 Category: Research Source Type: clinical trials

Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction
Condition:   Heart Failure With Reduced Ejection Fraction Intervention:   Drug: Empagliflozin 10 MG Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2023 Category: Research Source Type: clinical trials